- Home
- DAIO vs BCLI Comparison
DAIO vs BCLI Comparison
Compare DAIO & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAIO
- BCLI
- Stock Information
- Founded
- DAIO 1969
- BCLI 2000
- Country
- DAIO United States
- BCLI United States
- Employees
- DAIO N/A
- BCLI N/A
- Industry
- DAIO Electrical Products
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DAIO Industrials
- BCLI Health Care
- Exchange
- DAIO Nasdaq
- BCLI Nasdaq
- Market Cap
- DAIO 24.2M
- BCLI 25.0M
- IPO Year
- DAIO N/A
- BCLI N/A
- Fundamental
- Price
- DAIO $2.63
- BCLI $1.10
- Analyst Decision
- DAIO Strong Buy
- BCLI Strong Buy
- Analyst Count
- DAIO 1
- BCLI 1
- Target Price
- DAIO $4.00
- BCLI $30.00
- AVG Volume (30 Days)
- DAIO 26.1K
- BCLI 125.6K
- Earning Date
- DAIO 10-24-2024
- BCLI 11-22-2024
- Dividend Yield
- DAIO N/A
- BCLI N/A
- EPS Growth
- DAIO N/A
- BCLI N/A
- EPS
- DAIO N/A
- BCLI N/A
- Revenue
- DAIO $23,458,000.00
- BCLI N/A
- Revenue This Year
- DAIO N/A
- BCLI N/A
- Revenue Next Year
- DAIO $4.17
- BCLI N/A
- P/E Ratio
- DAIO N/A
- BCLI N/A
- Revenue Growth
- DAIO N/A
- BCLI N/A
- 52 Week Low
- DAIO $2.29
- BCLI $1.05
- 52 Week High
- DAIO $3.99
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- DAIO 53.89
- BCLI 18.33
- Support Level
- DAIO $2.54
- BCLI $1.12
- Resistance Level
- DAIO $2.70
- BCLI $1.95
- Average True Range (ATR)
- DAIO 0.11
- BCLI 0.20
- MACD
- DAIO -0.00
- BCLI -0.02
- Stochastic Oscillator
- DAIO 50.00
- BCLI 1.75
About DAIO Data I/O Corporation
Data I/O Corp is a provider of programming, security deployment, security provisioning and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in United States, Europe and Rest of the world.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.